celiprolol has been researched along with Aging in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity." | 6.38 | Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly. ( Lamon, KD, 1991) |
"Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity." | 2.38 | Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly. ( Lamon, KD, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lamon, KD | 1 |
1 review available for celiprolol and Aging
Article | Year |
---|---|
Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Celiprolol; Humans; Hypertension; Product Surveillance, Po | 1991 |